What is AbbVie's investing cash flow?

AbbVie (ABBV) reported investing cash flow of -$574M in Q1 2026.

How has AbbVie's investing cash flow changed year-over-year?

AbbVie's investing cash flow increased by 21.9% year-over-year, from -$735M to -$574M.

What is the long-term trend for AbbVie's investing cash flow?

Over 3 years (2021 to 2025), AbbVie's investing cash flow has grown at a 41.5% compound annual growth rate (CAGR), from -$2.34B to -$6.64B.

What does investing cash flow mean?

Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.

AbbVie ABBV Investing Cash Flow

Investing Cash Flow at other companies

Eli LillyLLY

-$3.92B-16.8%

PfizerPFE

$785M-76.0%

Johnson & JohnsonJNJ

-$1.04B-250%

AmgenAMGN

-$716M-60.2%

Cardinal HealthCAH

-$181M+93.8%

Vertex PharmaceuticalsVRTX

-$431.9M-674%

Other financials

Income statement

See full

Revenue$15.0B+12.4%

Gross profit$10.8B+15.4%

Operating income$4.0B+6.9%

Net income$695.0M-46.0%

EPS (diluted)$0.39-45.8%

Balance sheet

See full

Cash & equivalents$9.4B+81.5%

Total debt$62.4B+1.8%

Total equity-$6.7B-569%

Total assets$136.46B+0.2%

Cash flow

See full

Operating cash flow$3.8B+134%

CapEx$265.0M+12.8%

Free cash flow$3.6B+155%

Valuation

See full

Market cap$444.6B+34.7%

P/E122.3×+34.6×

P/S7.1×+1.4×

Profitability

See full

Gross margin70.7%0.0pp

Operating margin24.4%—

Net margin5.8%-1.5pp

FCF margin31.8%+5.0pp

Returns & leverage

See full

Return on equity89%+32.7pp

Debt / equity46.6×+38.6×

Current ratio0.8×0.0×

Where this comes from

Reported directly by AbbVie in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.

The official record: AbbVie’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about AbbVie's investing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is AbbVie's investing cash flow?: AbbVie (ABBV) reported investing cash flow of -$574M in Q1 2026.
How has AbbVie's investing cash flow changed year-over-year?: AbbVie's investing cash flow increased by 21.9% year-over-year, from -$735M to -$574M.
What is the long-term trend for AbbVie's investing cash flow?: Over 3 years (2021 to 2025), AbbVie's investing cash flow has grown at a 41.5% compound annual growth rate (CAGR), from -$2.34B to -$6.64B.
What does investing cash flow mean?: Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.